Genesis Healthcare Inc (NYSE:GEN) CFO Thomas Divittorio sold 10,318 shares of Genesis Healthcare stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $1.20, for a total value of $12,381.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of NYSE GEN traded down $0.01 during mid-day trading on Friday, hitting $1.28. 600 shares of the stock traded hands, compared to its average volume of 186,555. The firm has a market capitalization of $198.99 million, a PE ratio of -0.82 and a beta of 0.98. Genesis Healthcare Inc has a 52 week low of $1.10 and a 52 week high of $2.86.

Genesis Healthcare (NYSE:GEN) last announced its quarterly earnings data on Thursday, May 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.25) by $0.10. The company had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.17 billion. On average, research analysts predict that Genesis Healthcare Inc will post -0.78 EPS for the current year.

Separately, Credit Suisse Group restated a “hold” rating on shares of Genesis Healthcare in a research report on Monday, February 4th.

A number of large investors have recently made changes to their positions in GEN. Citigroup Inc. raised its stake in Genesis Healthcare by 74.3% during the fourth quarter. Citigroup Inc. now owns 34,936 shares of the company’s stock valued at $41,000 after buying an additional 14,893 shares during the last quarter. SG Americas Securities LLC purchased a new position in Genesis Healthcare during the first quarter valued at $45,000. Mackay Shields LLC purchased a new position in Genesis Healthcare during the fourth quarter valued at $59,000. Rhumbline Advisers raised its stake in Genesis Healthcare by 51.3% during the fourth quarter. Rhumbline Advisers now owns 68,297 shares of the company’s stock valued at $81,000 after buying an additional 23,160 shares during the last quarter. Finally, Spark Investment Management LLC raised its stake in Genesis Healthcare by 18.9% during the first quarter. Spark Investment Management LLC now owns 83,000 shares of the company’s stock valued at $119,000 after buying an additional 13,200 shares during the last quarter. Institutional investors and hedge funds own 21.31% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://theolympiareport.com/2019/05/24/insider-selling-genesis-healthcare-inc-gen-cfo-sells-10318-shares-of-stock.html.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Read More: How to Trade Using Analysts Ratings

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.